{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:31:48Z","timestamp":1793338308998,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402471"],"award-info":[{"award-number":["82402471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32171343"],"award-info":[{"award-number":["32171343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32471461"],"award-info":[{"award-number":["32471461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Haihe Laboratory of Cell Ecosystem Innovation Fund","award":["22HHXBSS00027"],"award-info":[{"award-number":["22HHXBSS00027"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1205803"],"award-info":[{"award-number":["2022YFA1205803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01785-8","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:06:50Z","timestamp":1774973210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CXCR4-antagonistic peptide-decorated lipid nanoparticles for co- delivery of AML1-ETO siRNA to enhance chemotherapy in refractory AML"],"prefix":"10.1186","volume":"19","author":[{"given":"Xuelu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"5","key":"1785_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM, Acute Myeloid L. 2025 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 2025;100(5):860\u201391.","journal-title":"Am J Hematol"},{"issue":"11","key":"1785_CR2","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41375-024-02326-3","volume":"38","author":"J Korbecki","year":"2024","unstructured":"Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I. CXCR4 as a therapeutic target in acute myeloid leukemia. Leukemia. 2024;38(11):2303\u201317.","journal-title":"Leukemia"},{"issue":"7","key":"1785_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1182\/blood.2023020857","volume":"143","author":"K Aoki","year":"2024","unstructured":"Aoki K, Hyuga M, Tarumoto Y, Nishibuchi G, Ueda A, Ochi Y, et al. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia. Blood. 2024;143(7):604\u201318.","journal-title":"Blood"},{"issue":"4","key":"1785_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/86515","volume":"7","author":"T Pabst","year":"2001","unstructured":"Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, et al. AML1-ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia. Nat Med. 2001;7(4):444\u201351.","journal-title":"Nat Med"},{"issue":"1","key":"1785_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","volume":"101","author":"RK Vangala","year":"2003","unstructured":"Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood. 2003;101(1):270\u20137.","journal-title":"Blood"},{"issue":"6","key":"1785_CR6","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-05-2944","volume":"66","author":"Y Choi","year":"2006","unstructured":"Choi Y, Elagib KE, Delehanty LL, Goldfarb AN. Erythroid Inhibition by the Leukemic Fusion AML1-ETO Is Associated with Impaired Acetylation of the Major Erythroid Transcription Factor GATA-1. Cancer Res. 2006;66(6):2990\u20136.","journal-title":"Cancer Res"},{"key":"1785_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-981-10-3233-2_11","volume":"962","author":"S Lin","year":"2017","unstructured":"Lin S, Mulloy JC, Goyama S. RUNX1-ETO Leukemia. Adv Exp Med Biol. 2017;962:151\u201373.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"1785_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bjh.16456","volume":"189","author":"EE Ladikou","year":"2020","unstructured":"Ladikou EE, Chevassut T, Pepper CJ, Pepper AGS. Dissecting the role of the CXCL12\/CXCR4 axis in acute myeloid leukaemia. Br J Haematol. 2020;189(5):815\u201325.","journal-title":"Br J Haematol"},{"key":"1785_CR9","doi-asserted-by":"crossref","unstructured":"Meng J, Ge Y, Xing H, Wei H, Xu S, Liu J et al. Synthetic CXCR4 Antagonistic Peptide Assembling with Nanoscaled Micelles Combat Acute Myeloid Leukemia. Small. 2020;16(31).","DOI":"10.1002\/smll.202001890"},{"issue":"4","key":"1785_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41375-023-01854-8","volume":"37","author":"H Issa","year":"2023","unstructured":"Issa H, Swart LE, Rasouli M, Ashtiani M, Nakjang S, Jyotsana N, et al. Nanoparticle-mediated targeting of the fusion gene RUNX1\/ETO in t(8;21)-positive acute myeloid leukaemia. Leukemia. 2023;37(4):820\u201334.","journal-title":"Leukemia"},{"issue":"24","key":"1785_CR11","doi-asserted-by":"publisher","first-page":"20121","DOI":"10.18632\/oncotarget.4041","volume":"6","author":"J Yu","year":"2015","unstructured":"Yu J, Qiu S, Ge Q, Wang Y, Wei H, Guo D, et al. A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells. Oncotarget. 2015;6(24):20121\u201331.","journal-title":"Oncotarget"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01785-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01785-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01785-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:06:52Z","timestamp":1774973212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01785-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01785-8","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This section has been described in the animal experiments and clinical sample experiments sections of the methods.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We will provide it when needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}